SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001062993-24-010187
Filing Date
2024-05-14
Accepted
2024-05-14 16:35:52
Documents
1
Period of Report
2024-03-21

Document Format Files

Seq Description Document Type Size
1 AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4a.html 4/A  
1 AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4a.xml 4/A 4384
  Complete submission text file 0001062993-24-010187.txt   5935
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Issuer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VACCINEX, INC. 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address
Sanchez Jill (Reporting) CIK: 0002015024 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38624 | Film No.: 24945064